ArticleDiabetes technology & therapeutics2022
Solutions to Address Inequity in Diabetes Technology Use in Type 1 Diabetes: Results from Multidisciplinary Stakeholder Co-creation Workshops.
Open access · hybridAbstract read
In one paragraph
Article in Diabetes technology & therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 31 citations in OpenAlex.
- Using technology to address disparities and promote healthcare equity in Type 1 Diabetes (EquiT1D) A nonrandomized clinical trial investigating solutions to low technology use.Journal of clinical & translational endocrinology · 2026Article
- Inequity in Continuous Glucose Monitor (CGM) Prescribing Behaviors in Primary Care.Journal of general internal medicine · 2026Article
- Barriers and Enablers to Diabetes Technologies Use Among Individuals With Type 1 Diabetes: A Scoping Review.Diabetes, obesity & metabolism · 2026Article
- Emotional Challenges Experienced along the Diabetes Technology Journey by Caregivers of Black and Hispanic/Latino Youth with Type 1 Diabetes.Hormone research in paediatrics · 2026Article
- Collaboration Around Technology Using Community Health Workers in Type 1 Diabetes (CATCH-T1D): Protocol and Preliminary Results for a Randomized Controlled Trial.Journal of diabetes research · 2026Article
- The Experience of Discrimination Impacts Technology Readiness and Psychosocial States of Minoritized Families Living With Type 1 Diabetes: Findings From the BEAD-T1D Pilot Study.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025Article
- The Role of Community Health Workers in Improving Diabetes Device Use Among Youth With Type 1 Diabetes: A Web-Based Qualitative Study Using Human-Centered Design With Clinicians.JMIR diabetes · 2025Article
- Association Between Self-Monitored Blood Glucose and Continuous Glucose Monitoring in Youth With Type 1 Diabetes and Medicaid Insurance.Diabetes care · 2025Article
- Understanding inequities in access to diabetes technologies in children and young people with type 1 diabetes: Qualitative study of healthcare professionals' perspectives and views.Diabetic medicine : a journal of the British Diabetic Association · 2025Article
- "I Just Wish That It Would Be Easier": Caregivers' Perspectives on Barriers and Proposed Solutions to Diabetes Technology Use for Non-Hispanic Black and Hispanic Youth With Type 1 Diabetes.Diabetes spectrum : a publication of the American Diabetes Association · 2025Article
- A Qualitative Analysis of Provider-Level Barriers to Prescribing Diabetes Technology.Journal of diabetes research · 2025Article
- System Failure in Type 1 Diabetes: What Stakeholders Need to Know to Expedite Therapeutic Options.Diabetes spectrum : a publication of the American Diabetes Association · 2025Article
- Article
- Achieving Digital Health Equity in Diabetes Care.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2024Article
- ROUTE-T1D: A behavioral intervention to promote optimal continuous glucose monitor use among racially minoritized youth with type 1 diabetes: Design and development.Contemporary clinical trials · 2024Article
- The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review.Therapeutic advances in endocrinology and metabolism · 2024Review
- Development of a Continuous Glucose Monitoring Service by Clinical Pharmacists in a Medically Underserved Population.Innovations in pharmacy · 2024Article
- Current evidence for designing self-management support for underserved populations: an integrative review using the example of diabetes.International journal for equity in health · 2023Review
- DiabetesWise: An innovative approach to promoting diabetes device awareness.Journal of diabetes · 2023Article
- Disparities in Hemoglobin A1c Levels in the First Year After Diagnosis Among Youths With Type 1 Diabetes Offered Continuous Glucose Monitoring.JAMA network open · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 2 countries.
Shivani AgarwalDivision of Endocrinology, Diabetes, and Metabolism, Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, New York, USA.ORCID 0000-0003-4506-3702
Gladys Crespo-RamosDivision of Endocrinology, Diabetes, and Metabolism, Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, New York, USA.
Stephanie L LeungDivision of Endocrinology, Diabetes, and Metabolism, Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, New York, USA.
Molly FinnanDivision of Endocrinology, Diabetes, and Metabolism, Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, New York, USA.
Tina ParkDiagram LLC, New York, New York, USA.
Katie McCurdyDiagram LLC, New York, New York, USA.
Jeffrey S GonzalezDivision of Endocrinology, Diabetes, and Metabolism, Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, New York, USA.
Judith A LongDivision of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Albert Einstein College of Medicine · USDiagram (Netherlands) · NLPhiladelphia VA Medical Center · US
Funding
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7MNew York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8MIdentifying and Reducing Disparities in Outcomes Among Economically Vulnerable and Minority Young Adults with Type 1 DiabetesK23DK115896 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI AGARWAL, SHIVANI · 2018 to 2022
$988kNIDDK NIH HHS K23 DK115896NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P30 DK111022
Abstract
PubMed holds no abstract for this paper.
Indexed as
Diabetes Mellitus, Type 1Blood GlucoseHumansRacial GroupsStakeholder ParticipationTechnologyUnited StatesBlood GlucoseDiabetes technologyDisparitiesInequityMinorityRace–ethnicityType 1 diabetes
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.